? ? The University of Virginia School of Medicine and Department of Pediatrics have a long track record and commitment to training clinician investigators. Ongoing training programs in Pediatric Cardiology and Nephrology have been very successful in producing independent clinician investigators. Based upon these successes in 1999 we proposed a new interdisciplinary training program for clinician investigators in Pediatric Cardiovascular Research with the goal to produce the future leaders in Academic Pediatrics. The new training grant increased the trainee pool, expanded the fellowship programs and helped recruit 20% minority applicants into the training program. We achieved our goal of 100% retention in the program and 6 out of the 7 graduates from the grant have entered academic careers. A unique feature of this program is that it provides opportunities for formal training in either a basic science or clinical investigation track. Half of our initial trainees have chosen the clinical investigation track and enrolled in Graduate degree programs in Health Evaluation Sciences or the non-degree Multi-disciplinary Training Program in Clinical Investigation sponsored by the NIH funded General Clinical Research Center. The basic science track involves close work with a primary mentor and collaboration with other mentors. Graduate courses and research centers including the NIH Center of Excellence in Pediatric Nephrology and the Cardiovascular Research Center provide further opportunities for training. The Mentors have a productive record of collaboration in research and research training and are committed to improving mentorship skills through the mentorship development program. The executive committee will provide structure and guidance for training and the Pediatric Fellows Training Program provides further didactic training and fosters an identity for the trainees. This training grant will continue to fill a growing need for research in pediatrics by offering cardiovascular research training to MD's in pediatric subspecialty training in cardiology or nephrology. (END OF ABSTRACT) ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007956-08
Application #
7222733
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Commarato, Michael
Project Start
2000-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
8
Fiscal Year
2007
Total Cost
$254,106
Indirect Cost
Name
University of Virginia
Department
Pediatrics
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Walker, Shetarra E; Smolkin, Mark E; O'Leary, M Layla L et al. (2012) Predictors of Retention and BMI Loss or Stabilization in Obese Youth Enrolled in a Weight Loss Intervention. Obes Res Clin Pract 6:e330-e339
Swanson, Jonathan R; Jilling, Tamas; Lu, Jing et al. (2011) Ileal Immunoglobulin Binding by the Neonatal Fc Receptor: A Previously Unrecognized Mechanism of Protection in the Neonatal Rat Model of Necrotizing Enterocolitis? EJ Neonatol Res 1:
Gordon, Phillip V; Herman, Andrew C; Marcinkiewicz, Marek et al. (2007) A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin. J Pediatr Gastroenterol Nutr 45:509-19
Grinsell, Matthew M; Showalter, Sharon; Gordon, Katherine A et al. (2006) Single kidney and sports participation: perception versus reality. Pediatrics 118:1019-27
Rice, Sydney A; Blackman, James A; Braun, Susan et al. (2005) Rehabilitation of children with traumatic brain injury: descriptive analysis of a nationwide sample using the WeeFIM. Arch Phys Med Rehabil 86:834-6
Rice, Sydney A; Allaire, Janet; Elgin, Kevin et al. (2004) Effect of shortened length of stay on functional and educational outcome after pediatric rehabilitation. Am J Phys Med Rehabil 83:27-32
Regan, Sara E; Broad, Michael; Byford, Anne M et al. (2003) A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol 284:H859-66